Alternatively, the low expression of low-density lipoprotein receptor-related protein (LRP-1) observed in patients with NAFLD may lead to decreased Aβ clearance (Tamaki et al., 2007). This evidence concerns the gene LRP1 and metabolic dysfunction-associated steatotic liver disease.